3D Bioprinted Fat‐Myocardium Model Unravels the Role of Adipocyte Hypertrophy in Atrial Dysfunction
Advanced Science · 2026-04 · 13 (23)
DOI: 10.1002/advs.202516114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.02.2026. Verfasst von Lara Ece Celebi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, USA. Hauptthemen laut MEDLINE: Adipocytes, Myocytes, Cardiac, Hypertrophy, Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NSF.
Abstract (Originalsprache)
Cardiovascular diseases (CVD) are the leading cause of mortality in individuals with obesity. Epicardial adipose tissue (EAT) dysfunction serves as a link between obesity and CVD, promoting inflammatory and metabolic alterations that increase CVD risk. While EAT normally supports cardiac health, obesity‐induced adipocyte hypertrophy triggers excessive fatty acid and cytokine release, driving myocardial lipotoxicity and inflammation that impair electrophysiology and metabolism, leading to beating irregularities, insulin resistance, and heart failure. The lack of sufficient EAT in small animal models and the impracticality of using large mammals hinder insights into the effects of EAT hypertrophy on the myocardium. To address this gap, a human‐derived 3D bioprinted coculture of obese adipocytes and cardiomyocytes (CMs) is developed using patient‐derived adipocytes and human induced pluripotent stem cell (hiPSC)‐derived atrial CMs (a‐iCMs). This platform enables the investigation of both cell‐cell and paracrine interactions between hypertrophic adipocytes and a‐iCMs, allowing assessment of electrophysiological, structural, and proteomic changes to uncover mechanisms linking EAT hypertrophy to obesity‐related atrial dysfunction. Screening of metformin, a cardioprotective drug, reveals improvement in electrophysiological function in hypertrophic adipocyte–a‐iCM cocultures. 3D bioprinted fat–myocardium model provides a high‐throughput platform to study obesity‐induced atrial dysfunction and facilitate the discovery of therapies for the obese heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, USA.
- Bioengineering Graduate Program, University of Notre Dame, Notre Dame, Indiana, USA.
- Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana, USA.
- Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
ORCID-Profile: Lara Ece Celebi, Pinar Zorlutuna
Förderung
- NCI NIH HHS
- NIH HHS
- NSF
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Celebi, L. E., & Zorlutuna, P. (2026). 3D Bioprinted Fat‐Myocardium Model Unravels the Role of Adipocyte Hypertrophy in Atrial Dysfunction. Advanced Science, 13(23). https://doi.org/10.1002/advs.202516114
Vancouver
Celebi LE, Zorlutuna P. 3D Bioprinted Fat‐Myocardium Model Unravels the Role of Adipocyte Hypertrophy in Atrial Dysfunction. Advanced Science. 2026;13(23). doi:10.1002/advs.202516114
BibTeX
@article{Celebi2026,
author = {Celebi, Lara Ece and Zorlutuna, Pinar},
title = {3D Bioprinted Fat‐Myocardium Model Unravels the Role of Adipocyte Hypertrophy in Atrial Dysfunction},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {23},
doi = {10.1002/advs.202516114}
}
EUVIMED